AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 13(1), 1964, pp. 100-107
Copyright © 1964 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basaca-Sevilla, V.
Right arrow Articles by Finkelstein, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basaca-Sevilla, V.
Right arrow Articles by Finkelstein, R. A.

Observations on Serological Responses to Cholera Immunization*

Virginia Basaca-Sevilla, T. P. Pesigan AND Richard A. Finkelstein
Bureau of Research and Laboratories, Department of Health, Manila, Republic of the Philippines, and Division of Communicable Disease and Immunology, Walter Reed Army Institute of Research, Washington, D. C. 20012

A comparison of the serological responses to several cholera vaccines and vaccine regimens has been conducted in groups of people in the Philippines. Responses to the vaccines and vaccine regimens, as determined by agglutination and vibriocidal antibody titrations, were observed to differ depending on the vaccine and dosage employed. Those vaccines which were most potent in active mouse protection assays elicited the best responses in the human subjects. Single doses of suitable vaccines were found to give nearly 100% serological response in small groups of individuals. Tests on a vaccine composed of El Tor vibrios showed it to be a safe and potent antigen in humans. It is recommended that consideration be given to the inclusion of El Tor vibrios in cholera vaccines for general use, although locally, in outbreaks of El Tor cholera, exclusive use of an El Tor vaccine would seem justified by the results of this investigation.


* Presented and discussed in the scientific meeting of the Philippine Society of Pathologists held at the Far Eastern University Institute of Medicine and Hospital, Manila, Philippines, 11 July 1963.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1964 by the American Society of Tropical Medicine and Hygiene.